Given that fascin inhibitors do not induce apoptosis of bladder cancer cells, we investigated the combinatory therapy of NP-G2-044 and a chemotherapeutics agent, cisplatin, which is widely used for treating metastatic bladder cancers. The gene discussed is FSCN1; the disease is urinary bladder carcinoma.